Monday August 14, 2000

COMPANY PRESS RELEASE

Transgenomic, Inc. Conference Call On the Web

LIVE Conference Call on the Web Notification Release

Transgenomic, Inc. Invites You to Join Its Second Quarter Conference Call on the Web

San Jose California and Omaha Nebraska, August 14 /PRNewswire/ -- In connection with Transgenomic, Inc.’s second quarter earnings release, you are invited to listen to its conference call that will be broadcast live over the Internet on Tuesday, August 15 at 8:30 a.m., EST, with Collin D’Silva, Chief Executive Officer. Transgenomic, Inc. will release its earnings on Tuesday, August 15 at 8:00 a.m. EST.

What: Transgenomic, Inc. Second Quarter Earnings Conference Call
When: Tuesday, August 15, 2000, 8:30 a.m. EST
Where: http://www.videonewswire.com/TRANSGENOMIC/081500/
How: Live over the Internet -- Simply log on to the web at the address above
Contact: Investor Relations, Transgenomic, Inc., 402-738-5437

Transgenomic provides innovative research tools to the genomics segment of the life sciences industry. These tools enable researchers to discover and understand variation in the human genetic code, or genome, in order to accelerate and improve drug development and diagnostics. We believe our WAVE System will become a leading tool to analyze genetic mutations. The WAVE System allows researchers to analyze both known and unknown genetic mutations faster, with more accuracy and at a lower cost than other commercially available techniques.

Please feel free to visit the company's Website: www.transgenomic.com

If you are unable to participate during the live webcast, the call will be archived on the Web site http://www.videonewswire.com/TRANSGENOMIC/081500/. A link to this will also be located on the company's Website.

(Minimum Requirements to listen to broadcast: The RealPlayer software, downloadable free from www.real.com/products/player/index.html, and at least a 14.4Kbps connection to the Internet. If you experience problems listening to the broadcast, send an e-mail to webmaster@vdat.com.)

For confirmation of release or further information contact:
Investor Relations
Transgenomic, Inc.
402-738-5437
Fax: 402-733-1264
investorrelations@transgenomic.com